Roche
US stocks rise on softer yields; Swiss franc strengthens after inflation surprise
U.S. benchmarks advance 0.4-0.6% at open as Treasury yields ease; SMI up 0.5% led by Roche and Logitech. Swiss inflation hits two-year high, lifting franc to 0.9392 per euro.
US stocks set for modest gain; SMI rises on Roche, Logitech gains; Swiss franc strengthens
U.S. futures point to a modestly higher open as Middle East tensions ease slightly. Swiss Market Index climbs 0.2% on Roche and Logitech gains, while the franc strengthens after Swiss inflation surprises.
Swiss Market Index falls 1.1% as heavyweights weigh on SMI
Partners Group gains 2.2%, Gurit surges 14% while Nestlé, Novartis and Roche decline. US tech rally lifts Nasdaq 100 to 29,518 as Nvidia, Salesforce and CrowdStrike advance.
Swiss shares rise as defensive stocks lead; gold rallies on softer jobs data
Swiss Market Index edges higher as Roche and other defensive stocks gain; gold jumps 0.63% on dovish US jobs report and weaker dollar. US semiconductor and software stocks diverge in premarket trading.
US stocks fluctuate as tech gains offset losses; SMI pares declines
Dow futures edge higher while Nasdaq 100 slips; energy price surge fuels inflation concerns ahead of Fed decision. Swiss market pares losses with defensive stocks leading gains.
Swiss stocks slip as oil, rate fears weigh on markets
SMI falls 0.4% as Brent crude tops $95, inflation and ECB/Fed policy expectations drive defensive rotation; Roche, Swiss Life gain while Amrize, Holcim lag.
Swiss equities slip as oil, inflation and rate fears weigh
SMI falls 0.4% to 14,280 as defensive shares lag; Amrize drops 2.7% after BofA downgrade, Roche and Swiss Life advance. Brent crude tops $95/bbl after U.S.-Iran strikes.
Nvidia lifts premarket U.S. stocks; Salesforce surges on outlook; SMI falls
U.S. futures rise as Nvidia’s results fuel AI optimism; Salesforce jumps 10% on raised revenue guidance. Swiss SMI declines 0.9% as heavyweights Nestlé, Novartis and Roche weigh.
Swiss equities drift as oil rises, Fed rate bets firm
SMI slips 0.24% as Brent crude tops $91/bbl on Middle East strikes; Holcim leads SMI laggards while Gurit, Kühne+Nagel gain. UBS faces regulatory scrutiny.
Swiss Market Index edges lower as heavyweights weigh amid oil spike
SMI slips 0.24% in narrow trading; Kühne+Nagel leads gains while Holcim, ABB lag. Brent crude rises 3.3% to $90.98 as Middle East tensions escalate.
Swiss equities slip on oil, Fed bets; Roche weighs on SMI
The Swiss Market Index fell 0.1% as Roche dragged, while Kühne+Nagel gained 1.4%. Brent crude rose 3.3% to $90.98 amid Middle East tensions and delayed Hormuz Strait talks.
Swiss stocks flat as oil rises, Fed rate hike bets weigh; Kühne+Nagel leads gains
The SMI traded little changed Monday as defensive stocks offset rising U.S. rate expectations and Brent crude topped $90 a barrel. Roche and Givaudan lagged while logistics firm Kühne+Nagel advanced.
Swiss Market Index shifts to 40% pharma weight after latest rebalancing
Healthcare now dominates the SMI after recent additions, raising concentration concerns but offering diversification within the sector itself.
Swiss Market Index rises 0.54% as ABB, Swisscom lead gains; Amrize hits record low
The SMI advanced to 14,525 points, supported by eurozone data and falling oil prices, while Amrize tumbled to an all-time low after another CFO departure. Swisscom, ABB and Sika led sector gains.
Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.
Swiss stocks rise as SMI nears record; Roche, Novartis lag; U.S. futures mixed
Swiss Market Index climbs 0.5% as construction shares lead gains; SAP downgraded by UBS despite raised price target. U.S. futures diverge ahead of Nvidia earnings and key data.
Nvidia lifts U.S. tech futures ahead of Wall Street open; SMI slips on heavyweights
Nvidia’s strong outlook drove semiconductor stocks higher in premarket trading, while Swiss blue chips fell as Nestlé, Novartis and Roche weighed on the SMI. Focus shifts to Jackson Hole Fed symposium.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Nvidia lifts premarket U.S. stocks; Swiss Market Index falls on heavyweights
Nvidia shares rose 5.9% in premarket trading after earnings, lifting Nasdaq futures 1% and S&P 500 futures 0.44%. Swiss Market Index fell 0.9% as Nestlé, Novartis and Roche weighed on the benchmark.
Swiss SMI dips 1% as Nestlé, Novartis, Roche weigh; Gurit surges 10%
Heavyweights drag Switzerland’s blue-chip index lower while Gurit jumps on strong earnings. Investors eye Jackson Hole for Fed clues amid elevated inflation and geopolitical risks.
Swiss SMI falls 0.8% as Nestlé, Novartis, Roche weigh; Gurit jumps 10%
Defensive heavyweights drag Switzerland's blue-chip index lower while chip-linked stocks rise on Nvidia earnings. Brent and WTI oil prices drop over 6% in a week amid Hormuz Strait talks.
Swiss SMI gains 0.5% as construction, tech stocks lead gains
SMI advances toward record high as Amrize, Holcim and Stadler Rail surge; Roche and Novartis weigh on index. Nvidia earnings awaited after U.S. and Asian gains.
Swiss stocks end flat as ABB, pharma weigh; UBS, Vetropack rise
The SMI slipped 0.07% to 14,447 as investors took profits on ABB and sold off Roche and Novartis. UBS gained 1.7% and Vetropack surged 4.4% on company-specific news.
Swiss equities slip as SMI lags; Roche, Novartis weigh; Richemont gains
Swiss benchmark SMI falls 0.25% to 14,423 as Roche and Novartis slide, while Richemont leads gains. US futures point to a softer open after a mixed week.